Interestingly, despite increased levels of TRIM3 and TRIM16 in human gastric cancer tissues, they showed a negative correlation with the β-catenin levels and some of its downstream targets in vitro, such as BCL2, suggesting their tumor-suppressing function [83,84]. The gene discussed is TRIM16; the disease is gastric cancer.